Last reviewed · How we verify
Pain associated with endometriosis — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Orgovyx | relugolix | MYOVANT SCIENCES | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | Gonadotropin-releasing hormone receptor | 2020-01-01 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- MYOVANT SCIENCES · 1 drug in Pain associated with endometriosis
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Pain associated with endometriosis:
- Pain associated with endometriosis treatment updates — RSS
- Pain associated with endometriosis treatment updates — Atom
- Pain associated with endometriosis treatment updates — JSON
Cite this brief
Drug Landscape (2026). Pain associated with endometriosis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/pain-associated-with-endometriosis. Accessed 2026-06-10.
Related
- Pain associated with endometriosis full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing